689
Views
13
CrossRef citations to date
0
Altmetric
Review

Engineering vaccinia virus as an immunotherapeutic battleship to overcome tumor heterogeneity

, , , & ORCID Icon
Pages 1083-1097 | Received 06 Jan 2020, Accepted 14 Apr 2020, Published online: 06 May 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Andrew T. Russo, Douglas W. Grosenbach, Jarasvech Chinsangaram, Kady M. Honeychurch, Paul G Long, Candace Lovejoy, Biswajit Maiti, Ingrid Meara & Dennis E. Hruby. (2021) An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications. Expert Review of Anti-infective Therapy 19:3, pages 331-344.
Read now

Articles from other publishers (12)

A-Rum Yoon, JinWoo Hong, Bo-Kyeong Jung, Hyo Min Ahn, Songnam Zhang & Chae-Ok Yun. (2023) Oncolytic adenovirus as pancreatic cancer-targeted therapy: Where do we go from here?. Cancer Letters 579, pages 216456.
Crossref
Palaniyandi Muthukutty & So Young Yoo. (2023) Oncolytic Virus Engineering and Utilizations: Cancer Immunotherapy Perspective. Viruses 15:8, pages 1645.
Crossref
Stephanie Riederer, Ana del Canizo, Javier Navas, Marlowe G. Peter, Ellen K. Link, Gerd Sutter & Juan J. Rojas. (2023) Improving poxvirus-mediated antitumor immune responses by deleting viral cGAMP-specific nuclease. Cancer Gene Therapy 30:7, pages 1029-1039.
Crossref
Nikolas T. Martin, Mathieu J. F. Crupi, Zaid Taha, Joanna Poutou, Jack T. Whelan, Sydney Vallati, Julia Petryk, Ricardo Marius, Bradley Austin, Taha Azad, Mason Boulanger, Tamara Burgess, Ilson Sanders, Camille Victoor, Bryan C. Dickinson, Jean-Simon Diallo, Carolina S. Ilkow & John C. Bell. (2023) Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy. Pharmaceuticals 16:5, pages 709.
Crossref
Jack T. Whelan, Ragunath Singaravelu, Fuan Wang, Adrian Pelin, Levi A. Tamming, Giuseppe Pugliese, Nikolas T. Martin, Mathieu J. F. Crupi, Julia Petryk, Bradley Austin, Xiaohong He, Ricardo Marius, Jessie Duong, Carter Jones, Emily E. F. Fekete, Nouf Alluqmani, Andrew Chen, Stephen Boulton, Michael S. Huh, Matt Y. Tang, Zaid Taha, Elena Scut, Jean-Simon Diallo, Taha Azad, Brian D. Lichty, Carolina S. Ilkow & John C. Bell. (2023) CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX. Frontiers in Immunology 13.
Crossref
Weilin Liu, Hongqi Chen, Zhi Zhu, Zuqiang Liu, Congrong Ma, Yong J. Lee, David L. Bartlett & Zong-Sheng Guo. (2022) Ferroptosis Inducer Improves the Efficacy of Oncolytic Virus-Mediated Cancer Immunotherapy. Biomedicines 10:6, pages 1425.
Crossref
Wen Lei, Qian Ye, Yuanyuan Hao, Jie Chen, Yu Huang, Liu Yang, Shibing Wang & Wenbin Qian. (2022) CD19-targeted BiTE expression by an oncolytic vaccinia virus significantly augments therapeutic efficacy against B-cell lymphoma. Blood Cancer Journal 12:2.
Crossref
Zongmin Zhao, Aaron C. Anselmo & Samir Mitragotri. (2021) Viral vector‐based gene therapies in the clinic . Bioengineering & Translational Medicine 7:1.
Crossref
Alberto Reale, Arianna Calistri & Jennifer Altomonte. (2021) Giving Oncolytic Viruses a Free Ride: Carrier Cells for Oncolytic Virotherapy. Pharmaceutics 13:12, pages 2192.
Crossref
Johannes P. W. Heidbuechel & Christine E. Engeland. (2021) Oncolytic viruses encoding bispecific T cell engagers: a blueprint for emerging immunovirotherapies. Journal of Hematology & Oncology 14:1.
Crossref
Masmudur M. Rahman & Grant McFadden. (2021) Oncolytic Viruses: Newest Frontier for Cancer Immunotherapy. Cancers 13:21, pages 5452.
Crossref
Cole W. D. Peters & Fares Nigim. (2021) Immunomodulatory Arming Factors—The Current Paradigm for Oncolytic Vectors Relies on Immune Stimulating Molecules. International Journal of Molecular Sciences 22:16, pages 9051.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.